Related Experiment Video
Updated: Oct 5, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Clinical and Economic Outcomes Associated With Remote Monitoring for Cardiac Implantable Electronic Devices: A
Derek S Chew1, Mahmood Zarrabi2, Isabelle You3
1O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada; Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
Remote monitoring (RM) for cardiac implantable electronic devices significantly lowers mortality and hospitalizations. This technology also offers substantial cost savings, supporting its broader adoption in healthcare.
Area of Science:
- Cardiology
- Health Economics
- Health Services Research
Background:
- Expert recommendations support remote monitoring (RM) for cardiac implantable electronic devices (CIEDs).
- Clinical implementation of RM remains limited due to funding inconsistencies and uncertainty about its impact on cardiovascular outcomes.
- Need for real-world evidence on RM's effectiveness and cost-efficiency.
Purpose of the Study:
- To evaluate the association of remote monitoring (RM) with mortality and cardiovascular hospitalizations in patients with de novo implantable cardioverter-defibrillators (ICDs) or cardiac resynchronization therapy with defibrillator (CRT-D) devices.
- To assess the direct health costs and economic benefits of RM compared to standard in-clinic follow-up.
- To construct a decision-analytic model for long-term cost-effectiveness projections.
Main Methods:
- Population-based cohort study using administrative health data from Alberta, Canada (2010-2016).
- Analysis of 2799 patients with de novo ICD or CRT-D devices, assessing RM status.
- Cox proportional hazards models for mortality/hospitalization; generalized linear models for costs; Markov model for economic projections.
Main Results:
- Remote monitoring (RM) was used in 63.4% of patients (n=1830) with a mean follow-up of 50.3 months.
- Adjusted analysis showed RM significantly reduced the risk of all-cause mortality (HR 0.43) and cardiovascular hospitalization (HR 0.76).
- Economic modeling projected 5-year cost savings of $12,195 per person with RM, observed in 99% of simulations.
Conclusions:
- Real-world data demonstrate that remote monitoring (RM) for CIEDs is associated with improved patient outcomes, including reduced mortality and hospitalizations.
- RM technology presents a cost-effective strategy, generating significant savings for the health system.
- Widespread implementation of RM is supported to enhance patient care and health system efficiency.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Holter Monitor: 24-Hour Monitoring
Cardiomyopathy V: Interprofessional Care

